Next Article in Journal
Targeted and Biomimetic Nanoparticles for Atherosclerosis Therapy: A Review of Emerging Strategies
Previous Article in Journal
Spike Timing-Dependent Plasticity and Random Inputs Shape Interspike Interval Regularity of Model STN Neurons
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Article

Hematological Parameter-Derived Inflammatory Scores in Non-Pancreatic Hyperlipasemia (NPHL)—The Prognosis Lies in the Blood

by
Krisztina Eszter Feher
1,2,†,
David Tornai
1,† and
Maria Papp
1,*
1
Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary
2
Kalman Laki Doctoral School of Biomedical and Clinical Sciences, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Biomedicines 2025, 13(7), 1719; https://doi.org/10.3390/biomedicines13071719 (registering DOI)
Submission received: 31 May 2025 / Revised: 1 July 2025 / Accepted: 10 July 2025 / Published: 14 July 2025
(This article belongs to the Section Molecular and Translational Medicine)

Abstract

Background/Objectives: Non-pancreatic hyperlipasemia (NPHL) is associated with high in-hospital mortality, with sepsis being one of the most common etiologies. The prognostic value of hematological parameter-derived inflammatory scores has not been extensively studied in NPHL to date. Methods: The prognostic value of eight inflammatory scores for in-hospital mortality was assessed in a total of 545 NPHL patients from two hospitalized patient cohorts (COVID-19 [n = 144] and non-COVID-19 [n = 401], the latter stratified as bacterial sepsis [n = 111] and absence of systemic infection [n = 290]). We assessed the neutrophil-to-lymphocyte ratio (NLR), derived NLR (dNLR), neutrophil-to-lymphocyte and platelet ratio (N/(LP)), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), aggregate index of systemic inflammation (AISI), systemic inflammation index (SII), and systemic inflammation response index (SIRI), comparing their prognostic value among etiological groups. Results: Patients with bacterial sepsis were older, had more comorbidities, and experienced worse outcomes, including longer hospitalization (median: 15, 7, and 11 days; p < 0.001), higher ICU admission rates (75.7%, 33.8%, and 47.9%, p < 0.001), and increased mortality (45.0%, 13.8%, and 38.2%, p < 0.001), compared to those without systemic infection or with COVID-19-induced NPHL. Overall, NLR, dNLR, and N/(LP) were the most accurate predictors of in-hospital mortality at admission (AUROC: non-infection: 0.747; 0.737; 0.772; COVID-19: 0.810; 0.789; 0.773, respectively). The accuracy of NLR decreased in bacterial sepsis, and only N/(LP) and PLR remained associated with in-hospital mortality (AUROC: 0.653 and 0.616, respectively). Conclusions: The prognostic performance of hematological parameter-derived inflammatory scores in NPHL is etiology-dependent. NLR is the most accurate prognostic tool for mortality in the absence of bacterial sepsis, while N/(LP) is the best score in sepsis-induced NPHL.
Keywords: elevated lipase; inflammation; bacterial infection; sepsis; viral infection; COVID-19; SARS-CoV-2; mortality; neutrophil-to-lymphocyte ratio elevated lipase; inflammation; bacterial infection; sepsis; viral infection; COVID-19; SARS-CoV-2; mortality; neutrophil-to-lymphocyte ratio

Share and Cite

MDPI and ACS Style

Feher, K.E.; Tornai, D.; Papp, M. Hematological Parameter-Derived Inflammatory Scores in Non-Pancreatic Hyperlipasemia (NPHL)—The Prognosis Lies in the Blood. Biomedicines 2025, 13, 1719. https://doi.org/10.3390/biomedicines13071719

AMA Style

Feher KE, Tornai D, Papp M. Hematological Parameter-Derived Inflammatory Scores in Non-Pancreatic Hyperlipasemia (NPHL)—The Prognosis Lies in the Blood. Biomedicines. 2025; 13(7):1719. https://doi.org/10.3390/biomedicines13071719

Chicago/Turabian Style

Feher, Krisztina Eszter, David Tornai, and Maria Papp. 2025. "Hematological Parameter-Derived Inflammatory Scores in Non-Pancreatic Hyperlipasemia (NPHL)—The Prognosis Lies in the Blood" Biomedicines 13, no. 7: 1719. https://doi.org/10.3390/biomedicines13071719

APA Style

Feher, K. E., Tornai, D., & Papp, M. (2025). Hematological Parameter-Derived Inflammatory Scores in Non-Pancreatic Hyperlipasemia (NPHL)—The Prognosis Lies in the Blood. Biomedicines, 13(7), 1719. https://doi.org/10.3390/biomedicines13071719

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop